296 related articles for article (PubMed ID: 22588443)
1. The current lymphoma classification: new concepts and practical applications triumphs and woes.
Bakshi N; Maghfoor I
Ann Saudi Med; 2012; 32(3):296-305. PubMed ID: 22588443
[TBL] [Abstract][Full Text] [Related]
2. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.
Campo E; Swerdlow SH; Harris NL; Pileri S; Stein H; Jaffe ES
Blood; 2011 May; 117(19):5019-32. PubMed ID: 21300984
[TBL] [Abstract][Full Text] [Related]
3. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
Ann Oncol; 1999 Dec; 10(12):1419-32. PubMed ID: 10643532
[TBL] [Abstract][Full Text] [Related]
4. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
Hematol J; 2000; 1(1):53-66. PubMed ID: 11920170
[TBL] [Abstract][Full Text] [Related]
5. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
Mod Pathol; 2000 Feb; 13(2):193-207. PubMed ID: 10697278
[TBL] [Abstract][Full Text] [Related]
6. Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Satou A; Bennani NN; Feldman AL
Expert Rev Hematol; 2019 Oct; 12(10):833-843. PubMed ID: 31365276
[No Abstract] [Full Text] [Related]
7. World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatology.
Russell-Jones R
J Am Acad Dermatol; 2003 Jan; 48(1):93-102. PubMed ID: 12522377
[TBL] [Abstract][Full Text] [Related]
8. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report.
Jaffe ES; Harris NL; Diebold J; Muller-Hermelink HK
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S8-12. PubMed ID: 9894466
[TBL] [Abstract][Full Text] [Related]
9. Towards a molecular classification of hematolymphoid neoplasms: where are we now? Where are we going?
Hsi ED
J Histochem Cytochem; 2001 Oct; 49(10):1323-4. PubMed ID: 11561018
[TBL] [Abstract][Full Text] [Related]
10. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
Histopathology; 2000 Jan; 36(1):69-86. PubMed ID: 10632755
[TBL] [Abstract][Full Text] [Related]
11. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
12. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J
Ann Oncol; 2000; 11 Suppl 1():3-10. PubMed ID: 10707771
[TBL] [Abstract][Full Text] [Related]
13. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
J Clin Oncol; 1999 Dec; 17(12):3835-49. PubMed ID: 10577857
[TBL] [Abstract][Full Text] [Related]
14. [Overview of lymphoid neoplasms in the fourth edition of the WHO classification].
Tohda S
Rinsho Byori; 2012 Jun; 60(6):560-4. PubMed ID: 22880234
[TBL] [Abstract][Full Text] [Related]
15. [New WHO classification of lymphoid neoplasms: understanding and consideration].
Li T; Yin H
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Feb; 35(1):94-8. PubMed ID: 12920820
[TBL] [Abstract][Full Text] [Related]
16. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Campo E; Jaffe ES; Cook JR; Quintanilla-Martinez L; Swerdlow SH; Anderson KC; Brousset P; Cerroni L; de Leval L; Dirnhofer S; Dogan A; Feldman AL; Fend F; Friedberg JW; Gaulard P; Ghia P; Horwitz SM; King RL; Salles G; San-Miguel J; Seymour JF; Treon SP; Vose JM; Zucca E; Advani R; Ansell S; Au WY; Barrionuevo C; Bergsagel L; Chan WC; Cohen JI; d'Amore F; Davies A; Falini B; Ghobrial IM; Goodlad JR; Gribben JG; Hsi ED; Kahl BS; Kim WS; Kumar S; LaCasce AS; Laurent C; Lenz G; Leonard JP; Link MP; Lopez-Guillermo A; Mateos MV; Macintyre E; Melnick AM; Morschhauser F; Nakamura S; Narbaitz M; Pavlovsky A; Pileri SA; Piris M; Pro B; Rajkumar V; Rosen ST; Sander B; Sehn L; Shipp MA; Smith SM; Staudt LM; Thieblemont C; Tousseyn T; Wilson WH; Yoshino T; Zinzani PL; Dreyling M; Scott DW; Winter JN; Zelenetz AD
Blood; 2022 Sep; 140(11):1229-1253. PubMed ID: 35653592
[TBL] [Abstract][Full Text] [Related]
17. Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice.
Jaffe ES; Barr PM; Smith SM
Am Soc Clin Oncol Educ Book; 2017; 37():535-546. PubMed ID: 28561690
[TBL] [Abstract][Full Text] [Related]
18. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.
Cazzola M
Blood; 2016 May; 127(20):2361-4. PubMed ID: 27069255
[No Abstract] [Full Text] [Related]
19. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.
Turner JJ; Morton LM; Linet MS; Clarke CA; Kadin ME; Vajdic CM; Monnereau A; Maynadié M; Chiu BC; Marcos-Gragera R; Costantini AS; Cerhan JR; Weisenburger DD
Blood; 2010 Nov; 116(20):e90-8. PubMed ID: 20699439
[TBL] [Abstract][Full Text] [Related]
20. Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?
Bain BJ; Ahmad S
Br J Haematol; 2014 Sep; 166(6):809-17. PubMed ID: 24913195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
